Key result
Supraventricular tachycardia treatment remains an urgent issue in modern cardiology, with both catheter ablation and antiarrhythmic therapy playing important roles depending on hemodynamics and QRS width.
Why the study?
The treatment of supraventricular tachycardia remains an urgent issue because antiarrhythmic therapy continues to play an important role despite the high effectiveness of catheter ablation.
This review highlights the ongoing importance of both catheter ablation and antiarrhythmic therapy in the modern management of supraventricular tachycardia.
Supraventricular tachycardia (SVT) is one of the most common arrhythmias. The prevalence of SVT varies widely in different countries and is 2,25 per 1,000 people in the general population. SVT reduce the quality of life of patients, and in some cases can worsen the prognosis. In patients with cardiovascular disease, the risk of SVT increases. Therapy of SVT is selected depending on the stability of hemodynamic and the QRS width. Until now, the treatment of SVT remains an urgent issue of modern cardiology, since despite the high effectiveness of catheter ablation, antiarrhythmic therapy plays an important role.
No takes yet. Share an insight, caveat, or question.
Тарзиманова et al. (2020) conducted a review in Supraventricular tachycardia (SVT). Catheter ablation and antiarrhythmic therapy was evaluated. Supraventricular tachycardia treatment remains an urgent issue in modern cardiology, with both catheter ablation and antiarrhythmic therapy playing important roles depending on hemodynamics and QRS width.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: